Informed-money record
BMRN · BIOMARIN PHARMACEUTICAL INC
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
1
Bearish filings
8
Named actors
4
Disclosed $ (bull / bear)
$40.2M / $6.3M
Recent disclosures
9 of 9 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-05-07 | EVP, Chief R&D Officer Friberg Gregory R | sold | $177K | SEC ↗ |
| 2026-05-07 | Officer (via Fidelity Brokerage Services LLC) Friberg Gregory R | filed notice to sell | $177K | SEC ↗ |
| 2026-03-31 | Institution (13F) VIKING GLOBAL INVESTORS LP | added to a position | $40.2M | — |
| 2026-03-11 | EVP, Chief Technical Officer Guyer Charles Greg | sold | $997K | SEC ↗ |
| 2026-03-11 | Officer (via Fidelity Brokerage Services LLC) Guyer Charles Greg | filed notice to sell | $997K | SEC ↗ |
| 2026-02-26 | EVP, Chief Legal Officer Davis George Eric | sold | $1.6M | SEC ↗ |
| 2026-02-26 | EVP, Chief R&D Officer Friberg Gregory R | sold | $382K | SEC ↗ |
| 2026-02-26 | Officer (via Fidelity Brokerage Services LLC) Davis George Eric | filed notice to sell | $1.6M | SEC ↗ |
| 2026-02-26 | Officer (via Fidelity Brokerage Services LLC) Friberg Gregory R | filed notice to sell | $382K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals